FDA approval of a generic extended-release tofacitinib formulation; this is a regulatory action record without clinical trial data or comparative efficacy evidence.
Reported
Approval date2026-06-09
Dose strength11 mg base
Loading
Company
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval of a generic extended-release tofacitinib formulation; this is a regulatory action record without clinical trial data or comparative efficacy evidence.